Associate Director, Country Head Quality Assurance - UK & Ireland at Moderna

London, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must have a pharmaceutical quality leadership background and serve as the Responsible Person (RP) and/or Responsible Person for Import (RPi) on the wholesale distribution license. They need to ensure compliance with GxP standards and EU GDP requirements, act as the primary quality interface with authorities, logistics partners, and internal stakeholders, and lead a dedicated quality team. Experience with enterprise digital systems, AI, and automation is a plus.

Responsibilities

The Associate Director will oversee Moderna’s pharmaceutical quality operations across the UK & Ireland, ensuring Good Distribution Practice (GDP) compliance and implementing the Quality Management System (QMS). Responsibilities include acting as the Management Representative, leading quality functions for government contracts, overseeing distribution systems, managing third-party logistics providers, preparing for inspections, making decisions on product disposition, managing customer complaints, and leading a quality team to foster collaboration and compliance excellence.

Skills

Quality Assurance

GxP

GDP

Pharmaceutical Quality

Regulatory Affairs

Leadership

Team Management

Batch Monitoring

Distribution

Stakeholder Management

Risk Management

Moderna

Develops mRNA-based medicines for health

About Moderna

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Cambridge, MassachusettsHeadquarters

2010Year Founded

$5,925.5MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

401(k) Company Match

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Risks

Potential backlash in Australia for bypassing vaccine safety steps.

Possible removal from Nasdaq 100 Index could affect investor confidence.

Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

Differentiation

Moderna is pioneering mRNA technology for new categories of medicines.

The company integrates AI to optimize mRNA design and production processes.

Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Upsides

Moderna received a $176 million contract for a bird flu vaccine.

The company is expanding mRNA applications to personalized cancer vaccines.

Moderna is establishing a domestic mRNA production facility in Australia.

Land your dream remote job 3x faster with AI

Try Jobo Free